Expertise in
4
conditions

Runming M. Jin

Union Hospital, 
Wuhan, CN 
Expertise in
4
conditions
Union Hospital, 
Wuhan, CN 

Overview

Runming Jin practices practicing medicine in Wuhan, China.

Jin is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Kozlowski Spondylometaphyseal Dysplasia, Leukemia, Pediatric Growth Hormone Deficiency, and Bone Marrow Aspiration.

They are actively involved in clinical research, co-authoring 78 peer reviewed articles and participating in 1 clinical trial.

Locations

Union Hospital, Wuhan, 430022, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Pivotal Phase 1/2, Single-Arm, Open-label Study to Evaluate the Safety and Efficacy of Ponatinib With Chemotherapy in Pediatric Patients With Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Who Have Relapsed or Are Resistant or Intolerant to a Prior Tyrosine Kinase Inhibitor-Containing Therapy, or Who Have the T315I Mutation
A Pivotal Phase 1/2, Single-Arm, Open-label Study to Evaluate the Safety and Efficacy of Ponatinib With Chemotherapy in Pediatric Patients With Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Who Have Relapsed or Are Resistant or Intolerant to a Prior Tyrosine Kinase Inhibitor-Containing Therapy, or Who Have the T315I Mutation
Enrollment Status: Terminated
Publish Date: October 02, 2025
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 1/Phase 2

78 Total Publications

A Novel LRP6 Mutation Highlights the Role of Wnt Signaling in Tooth Agenesis.
A Novel LRP6 Mutation Highlights the Role of Wnt Signaling in Tooth Agenesis.
Journal: Genesis (New York, N.Y. : 2000)
Published: September 02, 2025

Frequently Asked Questions about Runming M. Jin

Is Runming M. Jin a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?

MediFind is an objective health platform that identifies experts based on real-world data. Runming M. Jin is classified as an Advanced expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Runming M. Jin participate in research or clinical trials?

Yes. Runming M. Jin has published 78 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Runming M. Jin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Jin's expertise for a condition
ConditionClose
      View All 40 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile